David M. Livingston, M.D.
Emil Frei Professor of Medicine, Department of Medicine, Harvard Medical School
Professor, Department of Genetics, Harvard Medical School
Chairman, Executive Committee for Research, Dana-Farber Cancer Institute
Contact Info
David Livingston
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: SM870
Phone: 617-632-3074
Fax: 617-632-4381
david_livingston@dfci.harvard.edu
Executive Support Specialist
Cancer Biology
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: SM870
Phone: 617-632-3069
Fax: 617-632-4381
ann_desai@dfci.harvard.edu
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: SM870
Phone: 617-632-3074
Fax: 617-632-4381
david_livingston@dfci.harvard.edu
Assistant
Ann DesaiExecutive Support Specialist
Cancer Biology
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: SM870
Phone: 617-632-3069
Fax: 617-632-4381
ann_desai@dfci.harvard.edu
DF/HCC Program Affiliation
Cancer Cell BiologyCancer Genetics
Breast Cancer
DF/HCC Associations
Deputy Director, Dana-Farber/Harvard Cancer Center, Executive CommitteeMember, Center Scientific Council
Member, Clinical Science Coordinating Committee
Research Abstract
My research program is aimed at understanding the functional properties of four sets of nuclear proteins, each of which plays a major role in the suppression by human cells of certain transformed/neoplastic characteristics. They are the pocket protein family (pRB, p107, p130); p300 and CBP; p400 and TRRAP; and BRCA1 and 2. Analysis of the functions of BRCA1 and 2 as breast/ovarian cancer suppressing elements serve as our link to the Breast Cancer Program, and the work on the other three sets of transformation suppressing proteins underlie our participation in the Cancer Cell Biology Program. Futhermore, our laboratory contributes to an ongoing nodal point interaction between these two Programs. We are also working on converting elements of recent discovery of p300/CBP function into new screens for small molecule agents that interfere with hypoxia-driven tumor survival/proliferation responses.Publications
- Sobhian B, Shao G, Lilli DR, Culhane AC, Moreau LA, Xia B, Livingston DM, Greenberg RA.RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites.Science 2007 May 25;316(5828):1198-202.
17525341 - Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, Foulkes WD.Analysis of PALB2/FANCN-associated
17420451 - Silver DP, Dimitrov SD, Feunteun J, Gelman R, Drapkin R, Lu SD, Shestakova E, Velmurugan S, Denunzio N, Dragomir S, Mar J, Liu X, Rottenberg S, Jonkers J, Ganesan S, Livingston DM.Further evidence for BRCA1 communication with the inactive X chromosome.Cel
17350581 - Erkko H, Xia B, Nikkila J, Schleutker J, Syrjakoski K, Mannermaa A, Kallioniemi A, Pylkas K, Karppinen SM, Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA, Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen LA, Kosma VM, Ka
17287723 - Joukov V, Groen AC, Prokhorova T, Gerson R, White E, Rodriguez A, Walter JC, Livingston DM.The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly.Cell 2006 Nov 3;127(3):539-52.
17081976 - Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, Liu X, Jasin M, Couch FJ, Livingston DM.Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.Mol Cell 2006 Jun 23;22(6):719-29.
16793542 - Kim H, Livingston DM.A high mobility group protein binds to long CAG repeat tracts and establishes their chromatin organization in Saccharomyces cerevisiae.J Biol Chem 2006 Apr 9.
16603770 - Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A, Liao X, Iglehart JD, Livingston DM, Ganesan S.X chromosomal abnormalities in basal-like human breast cancer.Cancer Cell 2006 Feb;9(2):121-32.
16473279 - Greenberg RA, Sobhian B, Pathania S, Cantor SB, Nakatani Y, Livingston DM.Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.Genes Dev 2006 Jan 1;20(1):34-46.
16391231 - Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K.Aberrant T cell differentiation in the absence of Dicer.J Exp Med 2005 Jul 18;202(2):261-9.
16009718 - Elshamy WM, Livingston DM.Promoter usage of BRCA1-IRIS.Nat Cell Biol 2005 Apr;7(4):326.
15803127 - Samuelson AV, Narita M, Chan HM, Jin J, de Stanchina E, McCurrach ME, Narita M, Fuchs M, Livingston DM, Lowe SW.p400 is required for E1A to promote apoptosis.J Biol Chem 2005 Jun 10;280(23):21915-23.
15741165 - Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T, Livingston DM, Rajewsky K.Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing.Genes Dev 2005 Feb 15;19(4):489-501.
15713842 - Chan HM, Narita M, Lowe SW, Livingston DM.The p400 E1A-associated protein is a novel component of the p53 --> p21 senescence pathway.Genes Dev 2005 Jan 15;19(2):196-201.
15655109 - ElShamy WM, Livingston DM.Identification of BRCA1-IRIS, a BRCA1 locus product.Nat Cell Biol 2004 Oct;6(10):954-67.
15448696 - Taubert S, Gorrini C, Frank SR, Parisi T, Fuchs M, Chan HM, Livingston DM, Amati B.E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1.Mol Cell Biol 2004 May;24(10):4546-56.
15121871 - Wilson CA, Ramos L, Villaseņor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ, Slamon DJ.Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas.Nat Gen
9988281 - Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R.Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.Mol Cell 1998 Sep;2(3
9774970




